Dr. Alexander A. Azizi

Dr. Alexander A. Azizi is currently a Visiting Post Doctoral Scholar at the Broad Institute of MIT and Harvard, focusing on integrative multi-omic analyses of lung cancer samples under Professor Gad Getz. In addition, Dr. Azizi serves as a Drug Development Clinician at Weatherden and holds the position of NIHR Academic Clinical Fellow & Specialist Registrar in Medical Oncology, recognized as the top-ranked program in the UK. Previous roles include Lead for Bioinformatics and Companion Diagnostic Development at the Cancer Research UK Centre for Drug Development, and engagement in various consultative and advisory capacities across prominent organizations such as Sosei Heptares and Revena. Dr. Azizi's academic background encompasses multiple degrees from the University of Cambridge, including an MB BChir in Clinical Medicine and a BA MA in Preclinical Medicine, supplemented by advanced training in data science and pharmaceutical medicine.